Bernard Coulie, President and CEO: Pliant Therapeutics PLRX Sell · Filed 25/01/22

Trade details

Type: Insider sale
Amount: $587,092.8
Shares · price: 52,419 sh · $11.20 a share
Held after: 430,517 sh
Stock: Pliant Therapeutics PLRX
Person: Bernard CouliePresident and CEO
Trade date: 25/01/17
Filed: 25/01/22
Days to filing: 5 days

Sold 10.9% of holdings

Share of holding sold: 10.9%

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/18~25/02/16

Bernard Coulie's recent trades

Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$114.4K
89,375 sh
$114.4K
Filed 01/22
Traded 01/20
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$447.5K
38,710 sh
$447.5K
Filed 24/07/12
Traded 24/07/10
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$443.2K
25,721 sh
$443.2K
Filed 24/01/19
Traded 24/01/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$1.3M
70,150 sh
$1.3M
Filed 23/07/19
Traded 23/07/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$937.2K
35,339 sh
$937.2K
Filed 23/04/03
Traded 23/03/30